Unveiling the hidden risk of caspofungin: insights from three adverse event reporting systems and network pharmacology integration
This study highlights both expected and unexpected ADEs of caspofungin, emphasizing the importance of clinical vigilance and molecular research to enhance patient safety and therapeutic outcomes.
Authors
- Zhiwei Cui (ORCID: https://orcid.org/0000-0001-8338-4270)
- Zhengfu Li
- De Xie (ORCID: https://orcid.org/0000-0002-2127-0558)
- Fan Zou (ORCID: https://orcid.org/0000-0002-4436-6923)
- Chengyu Zhu (ORCID: https://orcid.org/0000-0002-2885-7394)
Institutions
- Zunyi Medical University (CN)
- Xiamen University (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-08-13
- DOI
- https://doi.org/10.3389/fphar.2025.1632488
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40